Does ATEZOLIZUMAB Cause Embolism? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Embolism have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.4% of all adverse event reports for ATEZOLIZUMAB.
147
Reports of Embolism with ATEZOLIZUMAB
0.4%
of all ATEZOLIZUMAB reports
24
Deaths
103
Hospitalizations
How Dangerous Is Embolism From ATEZOLIZUMAB?
Of the 147 reports, 24 (16.3%) resulted in death, 103 (70.1%) required hospitalization, and 7 (4.8%) were considered life-threatening.
Is Embolism Listed in the Official Label?
Yes, Embolism is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which ATEZOLIZUMAB Alternatives Have Lower Embolism Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN